FDA OKs Relistor for opioid patients

Apr 28, 2008

The U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients receiving opioids.

The FDA said opioids are often prescribed on a continuous basis for patients with late-stage, advanced illness to help alleviate pain, such as in cases of incurable cancer, heart failure and Alzheimer's disease with dementia.

But opioids can interfere with normal bowel movements by relaxing the intestinal smooth muscles and preventing them from contracting and pushing out waste products. Relistor acts by blocking opioid entrance into the cells, thus allowing the bowels to continue to function normally.

"This new drug will be helpful to patients who experience severe constipation associated with the continuous use of morphine or other opioids, which are an important part of care for patients with late-stage, advanced illness." said Dr. Joyce Korvick, deputy director of the FDA's division of gastroenterology products.

Relistor is manufactured by Wyeth Pharmaceuticals Inc. of Philadelphia and Progenics Pharmaceuticals of Tarrytown, N.Y.

Copyright 2008 by United Press International

Explore further: FDA OKs Merck tablet to reduce ragweed allergies

add to favorites email to friend print save as pdf

Related Stories

Android gains in US, basic phones almost extinct

36 minutes ago

The Google Android platform grabbed the majority of mobile phones in the US market in early 2014, as consumers all but abandoned non-smartphone handsets, a survey showed Friday.

Quest for extraterrestrial life not over, experts say

1 hour ago

The discovery of an Earth-sized planet in the "habitable" zone of a distant star, though exciting, is still a long way from pointing to the existence of extraterrestrial life, experts said Friday. ...

Recommended for you

Study recalculates costs of combination vaccines

23 hours ago

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

Pyridoxine-doxylamine drug safety data lacking

Apr 16, 2014

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

User comments : 0

More news stories